These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15962480)

  • 1. An oral delivery system for recombinant subunit vaccine to fish.
    Lin JH; Yu CC; Lin CC; Yang HL
    Dev Biol (Basel); 2005; 121():175-80. PubMed ID: 15962480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral immunization of Carassius auratus with modified recombinant A-layer proteins entrapped in alginate beads.
    Maurice S; Nussinovitch A; Jaffe N; Shoseyov O; Gertler A
    Vaccine; 2004 Dec; 23(4):450-9. PubMed ID: 15530693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved uptake of plant-derived LTB-linked proteins in carp gut and induction of specific humoral immune responses upon infeed delivery.
    Companjen AR; Florack DE; Slootweg T; Borst JW; Rombout JH
    Fish Shellfish Immunol; 2006 Sep; 21(3):251-60. PubMed ID: 16464614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral bacterial vaccine vectors for the delivery of subunit and nucleic acid vaccines to the organized lymphoid tissue of the intestine.
    Pascual DW; Powell RJ; Lewis GK; Hone DM
    Behring Inst Mitt; 1997 Feb; (98):143-52. PubMed ID: 9382735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.
    Walcher P; Mayr UB; Azimpour-Tabrizi C; Eko FO; Jechlinger W; Mayrhofer P; Alefantis T; Mujer CV; DelVecchio VG; Lubitz W
    Expert Rev Vaccines; 2004 Dec; 3(6):681-91. PubMed ID: 15606353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral vaccine delivery by recombinant spore probiotics.
    Cutting SM; Hong HA; Baccigalupi L; Ricca E
    Int Rev Immunol; 2009; 28(6):487-505. PubMed ID: 19954360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
    Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF
    J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immunization using recombinant plant-based oral vaccines.
    Streatfield SJ
    Methods; 2006 Feb; 38(2):150-7. PubMed ID: 16431131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.
    Zhu C; Ruiz-Perez F; Yang Z; Mao Y; Hackethal VL; Greco KM; Choy W; Davis K; Butterton JR; Boedeker EC
    Vaccine; 2006 May; 24(18):3821-31. PubMed ID: 16098637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-penetrating peptides mediated protein cross-membrane delivery and its use in bacterial vector vaccine.
    Ma J; Xu J; Guan L; Hu T; Liu Q; Xiao J; Zhang Y
    Fish Shellfish Immunol; 2014 Jul; 39(1):8-16. PubMed ID: 24746937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and immunoprotective analysis of an in vivo-induced Edwardsiella tarda antigen.
    Jiao XD; Dang W; Hu YH; Sun L
    Fish Shellfish Immunol; 2009 Nov; 27(5):633-8. PubMed ID: 19706328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmid maintenance systems suitable for GMO-based bacterial vaccines.
    Spreng S; Viret JF
    Vaccine; 2005 Mar; 23(17-18):2060-5. PubMed ID: 15755571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies of constructing recombinant vaccines.
    Sałamaszyńska-Guz A; Klimuszko D
    Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria.
    van Roosmalen ML; Kanninga R; El Khattabi M; Neef J; Audouy S; Bosma T; Kuipers A; Post E; Steen A; Kok J; Buist G; Kuipers OP; Robillard G; Leenhouts K
    Methods; 2006 Feb; 38(2):144-9. PubMed ID: 16414272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in fish vaccine delivery.
    Plant KP; Lapatra SE
    Dev Comp Immunol; 2011 Dec; 35(12):1256-62. PubMed ID: 21414351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?
    Lewis GK
    Expert Rev Vaccines; 2007 Jun; 6(3):431-40. PubMed ID: 17542757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid core peptide technology and group A streptococcal vaccine delivery.
    Olive C; Batzloff MR; Toth I
    Expert Rev Vaccines; 2004 Feb; 3(1):43-58. PubMed ID: 14761243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine potential of recombinant Ornithobacterium rhinotracheale antigens.
    Schuijffel DF; Van Empel PC; Segers RP; Van Putten JP; Nuijten PJ
    Vaccine; 2006 Mar; 24(11):1858-67. PubMed ID: 16318896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral vaccination with liposome-encapsulated recombinant fusion peptide of urease B epitope and cholera toxin B subunit affords prophylactic and therapeutic effects against H. pylori infection in BALB/c mice.
    Zhao W; Wu W; Xu X
    Vaccine; 2007 Nov; 25(44):7664-73. PubMed ID: 17913305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.